Running for only a few minutes a day or at slow speeds may significantly reduce a person’s risk of death from cardiovascular disease compared to someone who does not run, according to a clinical study published in the Journal of the American College of Cardiology.

Biotronik announced the completion of patient enrollment in the superficial femoral artery (SFA) arm of its BIOFLEX-I clinical trial, an U.S. Food and Drug Administration (FDA)-approved investigative device exemption (IDE) trial evaluating the use of self-expanding nitinol stents in treating peripheral artery disease.

August 7, 2014 — The Berlin Heart Group announced they have completed enrollment in their post-approval study, the only condition of the humanitarian device exemption (HDE) approval that Berlin Heart received for the Excor pediatric ventricular assist device (VAD) on Dec. 16, 2011.


August 7, 2014 — A newly released study by IMV Medical Information Division shows cardiology departments in U.S. hospitals are moving beyond separate cardiovascular image management systems (cardiac picture archiving and communications systems [PACS]) and information systems (CVIS), with an eye to the improved efficiency provided by integration with other capabilities such as radiology PACS, other departmental IT systems and the hospital’s EMR (electronic medical records) system.

Transluminal Technologies LLC, a Syracuse, NY-based medical device company, received CE mark approval for the velox CD Vascular Closure Device. 

Tryton Medical Inc. announced that the first patient has been enrolled in the EXTENDED Access Registry (Tryton IDE XA registry), a single arm clinical study of its Tryton Side Branch Stent. 

August 6, 2014 — St. Jude Medical announced the Center for Medicare and Medicaid Services (CMS) has approved a new technology add-on payment (NTAP) for the CardioMEMS heart failure (HF) monitoring system.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now